T1	Participants 70 107	regression of carotid atherosclerosis
T2	Participants 184 206	subjects with diabetes
T3	Participants 649 698	ypercholesterolemic subjects with type 2 diabetes
T4	Participants 886 942	A total of 97 subjects (51 pitavastatin; 46 pravastatin)
